Results 21 to 30 of about 141,012 (313)
Archives of Disease in Childhood, 2005 Commentary on the papers by Oddie et al (see page 119) and Escobar et al (see page 125) Two papers coincidentally submitted to Archives from opposite sides of the Atlantic give an opportunity to point out some interesting similarities and differences in the controversial area of hospital readmission shortly after birth.
openaire +2 more sources
Sex differences in hospital readmission among colorectal cancer patients. [PDF]
, 2005 Background: While several studies have analysed sex and socioeconomic differences in cancer incidence and mortality, sex differences in oncological health care have been seldom considered.
Peris, Mercè +7 more
core +1 more source
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021 Background The usefulness of right heart catherization (RHC) has long been debated, and thus, we aimed to study the real‐world impact of the use of RHC in cardiogenic shock.
Sagar Ranka +14 more
doaj +1 more source
Readmissions, Observation, and the Hospital Readmissions Reduction Program
New England Journal of Medicine, 2016 The Hospital Readmissions Reduction Program, which is included in the Affordable Care Act (ACA), applies financial penalties to hospitals that have higher-than-expected readmission rates for targeted conditions. Some policy analysts worry that reductions in readmissions are being achieved by keeping returning patients in observation units instead of ...
Rachael B, Zuckerman +4 more
openaire +2 more sources
Frontiers in Cardiovascular Medicine, 2021 Background: Whether digoxin is associated with increased mortality in atrial fibrillation (AF) remains controversial. We aimed to assess the risk of mortality and clinical effects of digoxin use in patients with AF.Methods: PubMed, Embase, and the ...
Xiaoxu Wang, Yi Luo, Dan Xu, Kun Zhao
doaj +1 more source
Revisiting Hospital Readmissions [PDF]
JAMA, 2013 Is your hospital addressing the readmission rate? Maybe efforts are underway, but pharmacy is not directly involved. Although many believe the readmission reduction program needs changes to better reflect quality care, the program is in place and likely impacts your institution. We provide a broad overview of the program and try to sensitize you to the
Phil B, Fontanarosa, Robert A, McNutt
openaire +4 more sources
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016 BackgroundLittle is known regarding the relationship between hospital performance on adverse event rates and hospital performance on 30‐day mortality and unplanned readmission rates for Medicare fee‐for‐service patients hospitalized for acute myocardial ...
Yun Wang +14 more
doaj +1 more source
Frontiers in Pediatrics, 2023 BackgroundThe definition of bronchopulmonary dysplasia (BPD) has been evolved recently from definition by the National Institute of Child Health and Human Development in 2001 (NICHD 2001) to the definition reported in 2018 (NICHD 2018) and that proposed ...
Jae Kyoon Hwang +4 more
doaj +1 more source
Heart-Failure-Readmission-Prediction
, 2023 Aims: Patients visiting the emergency department (ED) or hospitalized for heart failure (HF) are at increased risk for subsequent adverse outcomes, however effective risk stratification remains challenging.
Sunil Vasu Kalmady (10802896) +2 more
core +1 more source
Predictors of 30- and 90-Day COPD Exacerbation Readmission: A Prospective Cohort Study
International Journal of COPD, 2021 Jaber S Alqahtani,1,2 Yousef S Aldabayan,3 Abdulelah M Aldhahir,4 Ahmad M Al Rajeh,3 Swapna Mandal,1,5,* John R Hurst1,5,* 1UCL Respiratory, University College London, London, UK; 2Department of Respiratory Care, Prince Sultan Military College of
Alqahtani JS +5 more
doaj